Nirgundi Kashayam and Parijata Kashayam for Sciatica

Comparative Pharmacognostical and Clinical Study of Parijata (Nyctanthes arbor-tristis Linn) and Nirgundi (Vitex negundo Linn) as Vedanahara in Gridhrasi with Special Reference to Sciatica. - NIL

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078363

Enrollment

Registered

2024-12-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age between 20-60 years, irrespective of gender, caste, religion and socioeconomic status were selected for study Patients suffering with Low back ache radiating to lower limbs Patients presenting with lakshanas of gridhrasi

Exclusion criteria

Exclusion criteria: Patients suffering with below mentioned conditions will be excluded Uncontrolled Diabetes Mellitus and Hypertension Loss of bowel and bladder control Spondylolisthesis Vertebral Fractures Foot drop Psychiatric disorders Pottâ??s spine Post spinal surgical cases Severe systemic disorders Malignancy

Design outcomes

Primary

Measure	Time frame
The primary outcome of study is: Reduction in pain levels in patients with Gridhrasi (Sciatica). Measured using: Visual Analog Scale (VAS) & other parameters. Timepoint: The time points for the study are as follows: 1. Baseline Assessment: Conducted on Day 1 before starting the treatment. 2. Duration of Treatment: The treatment will be administered for 45 days. 3. Patient Reviews: Patients will be reviewed every 15 days during the treatment period (i.e., on Day 15, Day 30, and Day 45). 4. Follow-Up: A follow-up assessment will be conducted 30 days after completing the treatment.	—

Measure

Time frame

The primary outcome of study is: Reduction in pain levels in patients with Gridhrasi (Sciatica). Measured using: Visual Analog Scale (VAS) & other parameters. Timepoint: The time points for the study are as follows: 1. Baseline Assessment: Conducted on Day 1 before starting the treatment. 2. Duration of Treatment: The treatment will be administered for 45 days. 3. Patient Reviews: Patients will be reviewed every 15 days during the treatment period (i.e., on Day 15, Day 30, and Day 45). 4. Follow-Up: A follow-up assessment will be conducted 30 days after completing the treatment.

—

Secondary

Measure	Time frame
1) Functional improvement 2) Reduction in inflammation 3) Improvement in Range of motion 4) Patient satisfaction Timepoint: The time points for the study are as follows: 1. Baseline Assessment: Conducted on Day 1 before starting the treatment. 2. Duration of Treatment: The treatment will be administered for 45 days. 3. Patient Reviews: Patients will be reviewed every 15 days during the treatment period (i.e., on Day 15, Day 30, and Day 45). 4. Follow-Up: A follow-up assessment will be conducted 30 days after completing the treatment.	—

Measure

Time frame

1) Functional improvement 2) Reduction in inflammation 3) Improvement in Range of motion 4) Patient satisfaction Timepoint: The time points for the study are as follows: 1. Baseline Assessment: Conducted on Day 1 before starting the treatment. 2. Duration of Treatment: The treatment will be administered for 45 days. 3. Patient Reviews: Patients will be reviewed every 15 days during the treatment period (i.e., on Day 15, Day 30, and Day 45). 4. Follow-Up: A follow-up assessment will be conducted 30 days after completing the treatment.

—

Countries

India

Contacts

Public ContactDr. S. Baburao

Dr. BRKR Government Ayurvedic College

hayagrivavedatarupvtltd@gmail.com9885361326

Outcome results